Canada markets closed

ASLAN Pharmaceuticals Limited (ASLN)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.4471-0.0194 (-4.16%)
At close: 04:00PM EDT
0.4600 +0.01 (+2.89%)
After hours: 06:08PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 10.41M
Enterprise Value 15.98M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.63
Price/Book (mrq)2.14
Enterprise Value/Revenue 1.33
Enterprise Value/EBITDA -0.41

Trading Information

Stock Price History

Beta (5Y Monthly) 1.47
52-Week Change 3-89.78%
S&P500 52-Week Change 322.38%
52 Week High 34.6900
52 Week Low 30.3920
50-Day Moving Average 30.5938
200-Day Moving Average 31.1117

Share Statistics

Avg Vol (3 month) 31.24M
Avg Vol (10 day) 31.59M
Shares Outstanding 522.63M
Implied Shares Outstanding 624.38M
Float 8488.15M
% Held by Insiders 10.05%
% Held by Institutions 115.48%
Shares Short (Apr 15, 2024) 4250.19k
Short Ratio (Apr 15, 2024) 40.56
Short % of Float (Apr 15, 2024) 41.12%
Short % of Shares Outstanding (Apr 15, 2024) 41.11%
Shares Short (prior month Mar 15, 2024) 4290.51k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:5
Last Split Date 3Mar 13, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-364.46%

Management Effectiveness

Return on Assets (ttm)-63.71%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)12M
Revenue Per Share (ttm)0.73
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -43.71M
Net Income Avi to Common (ttm)-44.22M
Diluted EPS (ttm)-2.7500
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)21.25M
Total Cash Per Share (mrq)0.04
Total Debt (mrq)26.83M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.84
Book Value Per Share (mrq)-0.75

Cash Flow Statement

Operating Cash Flow (ttm)-46.64M
Levered Free Cash Flow (ttm)-30.01M